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ABSTRACT 
Background: Western acculturation has been shown to be detrimental to health 
outcomes. Recently, more Filipinos are migrating to New Zealand, which may increase 
lifestyle-related chronic diseases. Furthermore, Filipino populations already have a higher 
incidence of chronic disease and less favourable health outcomes than their Western 
counterparts. Understanding their risk will assist development of public health initiatives 
which can be utilised to protect the health of the growing Filipino New Zealand migrant 
population. Aim: The aim of this study was to investigate the risk of developing type 2 
diabetes mellitus and cardiovascular disease among recently immigrated Filipino women 
Method: 62 recently-immigrated Filipino women, aged 19-45, were recruited from 
Auckland, New Zealand. A health and demographic information questionnaire was 
completed. Anthropometric measurements (height, weight, and waist circumference) and 
blood pressure were measured. Both total and percent body fat were determined using 
dual energy X-ray absorptiometry. Fasting glucose, insulin, and lipids were measured. 
Physical activity data was monitored by accelerometers and two-day food diaries were 
completed. Homeostasis Model Assessment 2 was used to quantify insulin resistance. 
The 30-year Framingham Risk Score was used to classify participants into low-,   
medium-, or high-risk of developing cardiovascular disease. Prevalence of metabolic 
syndrome according to the modified National Cholesterol Education Programme criteria 
was determined. Results: Body mass index, waist circumference, and percent body fat 
were positively correlated with higher insulin resistance. Smokers had higher insulin 
resistance than non-smokers. However, 90% of participants had a low long-term risk of 
developing cardiovascular disease and 10% of participants met the metabolic syndrome 
criteria. This study was cross-sectional and provided used self-selection sampling. 
Conclusion: Anthropometric measures and smoking were associated with higher insulin 
resistance in participants. Participants with metabolic syndrome (10%) were at a greater 
risk of developing type 2 diabetes mellitus. This study highlights the risk of diabetes and 
cardiovascular disease development, and the need for further research, in this Filipino 
migrant population. These findings also create a platform for improving New Zealand 
health programmes by targeting appropriate risk factors to improve insulin sensitivity and 
reduce risk of developing diabetes, and will help to raise awareness in the Filipino 
community. 
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